Hepatitis B virus replication and liver disease progression: the impact of antiviral therapy

Yun-Fan Liaw1

  • 1Liver Research Unit, Chang Gung University, Taipei, Taiwan. liveryfl@so-net.net.tw

Antiviral Therapy
|February 22, 2007
PubMed

Insights

Chronic hepatitis B virus (HBV) infection requires effective suppression to prevent liver disease progression. Current therapies aim for sustained HBV replication control, but improved efficacy and reduced resistance are crucial goals.

Area of Science:

  • Hepatology
  • Virology
  • Oncology

Background:

  • Chronic hepatitis B virus (HBV) infection is a global health concern.
  • HBV replication markers like HBeAg and HBV DNA indicate ongoing hepatitis activity and disease progression, including cirrhosis and hepatocellular carcinoma (HCC).
  • Long-term studies show increased risk of progression with HBeAg positivity and HBV DNA levels above 10^4 copies/ml.

Purpose of the Study:

  • To highlight the critical need for HBV elimination or sustained suppression.
  • To discuss the role of antiviral therapies in reducing disease progression.
  • To emphasize the limitations of current treatments and the goal of achieving high suppression rates with low resistance.

Main Methods:

  • Review of long-term prospective studies in patients over 30 years of age.
  • Analysis of HBV replication markers (HBeAg, HBV DNA) and their correlation with disease progression.
  • Evaluation of existing therapies like interferon-alpha and direct antiviral agents.

Main Results:

  • HBeAg seropositivity and HBV DNA levels (≥10^4 copies/ml) are associated with increased risk of liver cirrhosis and HCC.
  • Antiviral therapy can reduce the risk of cirrhosis and disease worsening.
  • Maintained suppression of HBV replication may decrease HCC progression.

Conclusions:

  • Sustained suppression of HBV replication is essential for preventing hepatitis and halting disease progression.
  • Current antiviral therapy efficacy is limited, necessitating the development of more effective treatments.
  • The ultimate goal is achieving high rates of sustained HBV suppression with minimal drug resistance.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...